https://orcid.org/0000-0003-0333-0059
References
- Frenck Jr. RW, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents. N Engl J Med. 2021;385(3):239-250. doi:10.1056/NEJMoa2107456
- Olson SM, Newhams MM, Halasa NB, et al. Effectiveness of BNT162b2 vaccine against critical COVID-19 in adolescents. N Engl J Med. 2022;386(8):713–723. doi:10.1056/NEJMoa2117995
- Lai FTT, Li X, Peng K, et al. Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: A case-control study. Ann Intern Med. 2022.
- Ling RR, Ramanathan K, Tan FL, et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. The Lancet Respiratory Medicine. 2022.
- Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. Br Med J. 2021;375(e068665.
- Chua GT, Kwan MYW, Chui CSL, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following comirnaty vaccination. Clin Infect Dis. 2021.
- Das BB, Kohli U, Ramachandran P, et al. Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of Age. J Pediatr. 2021;238:26–32. e1. doi:10.1016/j.jpeds.2021.07.044
- Dionne A, Sperotto F, Chamberlain S, et al. Association of myocarditis With BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021;6(12):1446–1450. doi:10.1001/jamacardio.2021.3471
- Jain SS, Steele JM, Fonseca B, et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021;148(5)
- Patel T, Kelleman M, West Z, et al. Comparison of multisystem inflammatory syndrome in children-related myocarditis. classic viral myocarditis, and COVID; 19, vaccine-related myocarditis in children. J Am Heart Assoc. 2022;11(9):e024393.
- Shiyovich A, Witberg G, Aviv Y, et al. Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. 2021.
- Truong DT, Dionne A, Muniz JC, et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation. 2022;145(5):345–356. doi:10.1161/CIRCULATIONAHA.121.056583
- Woo W, Kim AY, Yon DK, et al. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine. J Med Virol. 2022;94(4):1566–1580. doi:10.1002/jmv.27501
- Investigating Long-Term Effects of Myocarditis: Centers for Disease Control and Prevention; 2022 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myo-outcomes.html.
- Myocarditis/Pericarditis Case Definition: Brighton Collaboration; [Available from: https://brightoncollaboration.us/myocarditis-case-definition-update/.
- Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the sport cardiology section of the European association of preventive cardiology (EAPC). Eur Heart J. 2018;40(1):19–33. doi:10.1093/eurheartj/ehy730
- Zou H, Yin P, Liu L, et al. Body-Weight fluctuation Was associated With increased risk for cardiovascular disease, All-cause and cardiovascular mortality: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2019;10.
- Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States: Centers for Disease Control and Prevention; 2022 [Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html.
- Rosa Duque J, Wang X, Leung D, Cheng S, Cohen C, Xiaofeng M, et al. Immunogenicity and reacto-genicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents. Nat Commun. 2022;In-press.